Type 1 Diabetes Development Requires Both CD4+ and CD8+ T cells and Can Be Reversed by Non-Depleting Antibodies Targeting Both T Cell Populations . The Review of Diabetic Studies , [S. l.], v. 6, n. 2, 2023. Disponível em: https://www.diabeticstudies.org/index.php/RDS/article/view/259. Acesso em: 21 sep. 2025.